Small size of orthogonal array in muscle plasma membrane of Fukuyama type congenital muscular dystrophy

1986 ◽  
Vol 72 (2) ◽  
pp. 130-133 ◽  
Author(s):  
Y. Wakayama ◽  
T. Kumagai ◽  
T. Jimi
1994 ◽  
Vol 20 (5) ◽  
pp. 487-494 ◽  
Author(s):  
S. Shibuya ◽  
Y. Wakayama ◽  
T. Jimi ◽  
H. Oniki ◽  
T. Kobayashi ◽  
...  

1981 ◽  
Vol 54 (3) ◽  
pp. 189-197 ◽  
Author(s):  
D. L. Schotland ◽  
E. Bonilla ◽  
Y. Wakayama

Neurology ◽  
1983 ◽  
Vol 33 (10) ◽  
pp. 1346-1346 ◽  
Author(s):  
E. Bonilla ◽  
K. H. Fischbeck ◽  
D. L. Schotland

1995 ◽  
Vol 53 (3a) ◽  
pp. 416-423 ◽  
Author(s):  
Lineu Cesar Werneck ◽  
Eduardo Bonilla

The dystrophin distribution in the plasma muscle membrane using immunohystochemistry was studied in 22 children with congenital muscular dystrophy. The dystrophin was detected by immunofluorescence in muscle biopsy through a polyclonal antibody. All the cases had patchy interruptions of the fluorescence in the plasma membrane. A large patchy interruption of the sarcolemma was found in 17 cases, small interruption in 12, and a combination of large and small patchy discontinuity in 7. Small gaps around the fiber like a rosary were found in 15 cases. The frequency of these abnormalities ranged cases from: all fibers in 5 cases, frequent in 8, occasional in 5, and rare in 4. Five cases had total absence of immunofluorescence. These results suggest that the dystrophin expression is abnormal in this group of children and that this type of abnormalities can not be differentiated from early Becker muscular dystrophy nor childhood autosomal recessive muscular dystrophy through immunohystochemistry alone.


1979 ◽  
Vol 57 (5) ◽  
pp. 983-986 ◽  
Author(s):  
Burr G. Atkinson ◽  
Richard R. Shivers ◽  
Bruce Nixon ◽  
Kristine H. Atkinson

The plasma membrane of red blood cells from mice afflicated with congenital muscular dystrophy exhibits a dramatic depletion of intramembrane particles. Examination of protein particles on fracture faces of erythrocyte plasma membranes from dystrophic mice revealed a 33% decrease in the number of intramembrane particles when compared with similarly prepared erythrocytes from nondystrophic animals. This alteration in the internal molecular architecture of these plasma membranes is correlated with the morphological distortion manifested by most red blood cells from mice inflicted with this genetic disorder.


2002 ◽  
Vol 59 (3) ◽  
pp. 431 ◽  
Author(s):  
Yoshihiro Wakayama ◽  
Takahiro Jimi ◽  
Masahiko Inoue ◽  
Hiroko Kojima ◽  
Makoto Murahashi ◽  
...  

1999 ◽  
Vol 145 (1) ◽  
pp. 153-165 ◽  
Author(s):  
Rachelle H. Crosbie ◽  
Connie S. Lebakken ◽  
Kathleen H. Holt ◽  
David P. Venzke ◽  
Volker Straub ◽  
...  

The dystrophin–glycoprotein complex (DGC) is a multisubunit complex that spans the muscle plasma membrane and forms a link between the F-actin cytoskeleton and the extracellular matrix. The proteins of the DGC are structurally organized into distinct subcomplexes, and genetic mutations in many individual components are manifested as muscular dystrophy. We recently identified a unique tetraspan-like dystrophin-associated protein, which we have named sarcospan (SPN) for its multiple sarcolemma spanning domains (Crosbie, R.H., J. Heighway, D.P. Venzke, J.C. Lee, and K.P. Campbell. 1997. J. Biol. Chem. 272:31221–31224). To probe molecular associations of SPN within the DGC, we investigated SPN expression in normal muscle as a baseline for comparison to SPN's expression in animal models of muscular dystrophy. We show that, in addition to its sarcolemma localization, SPN is enriched at the myotendinous junction (MTJ) and neuromuscular junction (NMJ), where it is a component of both the dystrophin– and utrophin–glycoprotein complexes. We demonstrate that SPN is preferentially associated with the sarcoglycan (SG) subcomplex, and this interaction is critical for stable localization of SPN to the sarcolemma, NMJ, and MTJ. Our experiments indicate that assembly of the SG subcomplex is a prerequisite for targeting SPN to the sarcolemma. In addition, the SG– SPN subcomplex functions to stabilize α-dystroglycan to the muscle plasma membrane. Taken together, our data provide important information about assembly and function of the SG–SPN subcomplex.


Neurology ◽  
1983 ◽  
Vol 33 (10) ◽  
pp. 1368-1368 ◽  
Author(s):  
Y. Wakayama ◽  
E. Bonilla ◽  
D. L. Schotland

Sign in / Sign up

Export Citation Format

Share Document